申请人:Boehringer Ingelheim International GmbH
公开号:US20180086748A1
公开(公告)日:2018-03-29
The present invention encompasses compounds of the formula (I)
wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.